Reduction in defibrillation threshold by modifications to the subcutaneous implantable-cardioverter defibrillator coil.
Resource Type
Editorial & Opinion
Authors
Heist EK; Cardiac Arrhythmia Service, Massachusetts General Hospital, Boston, Massachusetts. Electronic address: kheist@mgh.harvard.edu.; Knops RE; Department of Clinical and Experimental Cardiology, Heart Center, Amsterdam Medical Center, University of Amsterdam, Amsterdam, the Netherlands.; Yap SC; Department of Cardiology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, the Netherlands.; Boersma LVA; St. Antonius Hospital, Nieuwegein, the Netherlands.; Friedman DJ; Department of Cardiology, Electrophysiology Section, Duke University Hospital, Durham, North Carolina.; Poole JE; Department of Cardiology, University of Washington, Seattle, Washington.; Stahl W; Boston Scientific, St. Paul, Minneapolis, Minnesota.; Belalcazar A; Biophysicist, Minneapolis, Minnesota.
Source
Publisher: Elsevier Country of Publication: United States NLM ID: 101200317 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1556-3871 (Electronic) Linking ISSN: 15475271 NLM ISO Abbreviation: Heart Rhythm Subsets: MEDLINE